CLINICAL_TRIALS
trial_result
· 2009-09-22
Clinical Trial Update: Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies [Phase 2]
Summary
A Phase 2 clinical trial evaluating the efficacy of Faslodex (fulvestrant) for systemic lupus erythematosus has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Center for Rheumatic Disease, Allergy, & Immunology | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED